FDA panel backs ‘female Viagra’ with safety restriction

The Food and Drug Administration panel voted 18-6 in favor of approving Sprout Pharmaceutical’s daily pill flibanserin, on the condition that its manufacturer develops a plan to limit safety risks. Flibanserin More...

Pfizer not Impotent in Face of Alleged Infringement on Viagra Patent

– /By Itzhak Dannon / The American company Pfizer, the world’s largest pharmaceutical company, recently filed a civil suit in Tel Aviv District Court, seeking  monetary relief to the tune More...